Establishment of novel in vitro assay for evaluation of killing effect of chloroquine against malaria parasite

评价氯喹对疟原虫杀灭作用的新型体外测定方法的建立

• 批准号: 20K16238
• 负责人: バリカガラ ベテイ
• 金额: $ 2.75万
• 依托单位: Juntendo University
• 依托单位国家: 日本
• 项目类别: Grant-in-Aid for Early-Career Scientists
• 财政年份: 2020
• 资助国家: 日本
• 起止时间: 2020-04-01 至 2024-03-31
• 项目状态: 已结题
• 来源: https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-20K16238/
• 关键词: Plasmodium; Chloroquine; Plasmodium falciparum; Cytociday efficacy; Africa; Cytocidal-efficacy; Novel; In-vitro assay; マラリア; クロロキン

After completing the first step of confirming the chloroquine parasiticidal effect using the laboratory cultured standard strains: chloroquine sensitive (HB3) and resistant parasites: Dd2 (Southeast Asian origin) and 7G8 (South American origin) according to the method of a previous study (Paguio, Mol Biochem Parasitol 2011), the next step was to verify the parasiticidal chloroquine effect using cryopreserved natural parasites recovered from Uganda field site. First by recovering cryopreserved field natural uganda parasites and adapt them to continuous culture in the laboratory. Once successful then perform chloroquine cytocidal drug assay.Last year, parasite recovery and adaptation into culture failed because the used parasites had been collected in EDTA that hindered parasite growth. We changed the protocol to collect fresh parasite isolates in ACD-A that supports parasite growth.From Feburary-March 2022 and October-November 2022, two field surveys have been completed in Uganda and 135 fresh parasite isolates (29 in Feb-March 2022 and 106 in Oct-Nov 2022) have been collected. The cryopreserved parasites have been shipped from Uganda to Japan. Parasite recovery and adaptation of these field parasites into continuous culture is ongoing.

使用实验室培养的标准菌株：氯喹敏感（HB 3）和抗性寄生虫，完成确认氯喹杀寄生虫作用的第一步后：DD2（东南亚起源）和7G8（南美起源）根据以前的研究方法（Paguio，Mol Biochem Parasitol 2011），下一步是使用从乌干达野外回收的冷冻保存的天然寄生虫来验证杀寄生虫氯喹的效果。首先通过恢复冷冻保存的野外天然乌干达寄生虫，并使其适应实验室中的连续培养。去年，寄生虫的恢复和适应培养失败，因为使用的寄生虫被收集在EDTA中，阻碍了寄生虫的生长。2022年2月至3月和2022年10月至11月，我们在乌干达完成了两次实地调查，共收集了135个新鲜寄生虫分离株（2022年2月至3月29个，2022年10月至11月106个）。冷冻保存的寄生虫已从乌干达运往日本。正在进行寄生虫恢复和这些田间寄生虫适应连续培养。

项目成果

The impact of sequestration on artemisinin-induced parasite clearance in Plasmodium falciparum malaria in Africa.

非洲恶性疟原虫疟疾中封存对青蒿素诱导的寄生虫清除的影响。

• DOI: 10.1093/cid/ciac944
• 发表时间: 2022
• 期刊: Clin Infect Dis.
• 作者: Fukuda N;Balikagala B;Ueno T;Anywar DA;Kimura E;Palacpac NMQ;Odongo-Aginya EI;Ogwang M;Horii T;Miida T;Mita T.
• 通讯作者: Mita T.

Efficacy of piperaquine drug in Northern Uganda,a region where artemisinin resistance has emerged

哌喹药物在青蒿素耐药性乌干达北部地区的疗效

• 发表时间: 2022
• 作者: Kanoi Bernard N.;Nagaoka Hikaru;Morita Masayuki;White Michael T.;Palacpac Nirianne M.Q.;Ntege Edward H.;Balikagala Betty;Yeka Adoke;Egwang Thomas G.;Horii Toshihiro;Tsuboi Takafumi;Takashima Eizo;Balikagala Betty;Betty Balikagala;Betty Balikagala;Betty Balikagala
• 通讯作者: Betty Balikagala

St. Mary's Hospital Lacor Hospital/PO Box 180/Gulu Uganda(ウガンダ)

圣玛丽医院 Lacor Hospital/PO Box 180/Gulu 乌干达

Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in Northern Uganda

• DOI: 10.1016/j.parint.2020.102277
• 发表时间: 2021-04-01
• 期刊: PARASITOLOGY INTERNATIONAL
• 影响因子: 1.9
• 作者: Fukuda，Naoyuki;Tachibana，Shin-Ichiro;Mita，Toshihiro
• 通讯作者: Mita，Toshihiro

Global Repertoire of Human Antibodies Against Plasmodium falciparum RIFINs, SURFINs, and STEVORs in a Malaria Exposed Population

• DOI: 10.3389/fimmu.2020.00893
• 发表时间: 2020-05-12
• 期刊: FRONTIERS IN IMMUNOLOGY
• 影响因子: 7.3
• 作者: Kanoi，Bernard N.;Nagaoka，Hikaru;Takashima，Eizo
• 通讯作者: Takashima，Eizo